Cross Country Healthcare, Inc.
CCRN
$15.93
$0.130.82%
| Weiss Ratings | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.00 | |||
| Price History | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.87% | |||
| 30-Day Total Return | -12.71% | |||
| 60-Day Total Return | -11.89% | |||
| 90-Day Total Return | 34.89% | |||
| Year to Date Total Return | -12.33% | |||
| 1-Year Total Return | -14.54% | |||
| 2-Year Total Return | -36.10% | |||
| 3-Year Total Return | -21.57% | |||
| 5-Year Total Return | 95.22% | |||
| 52-Week High % Change | -17.92% | |||
| 52-Week Low % Change | 64.93% | |||
| Price | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $19.25 | |||
| 52-Week Low Price | $9.58 | |||
| 52-Week Low Price (Date) | Nov 14, 2024 | |||
| 52-Week High Price (Date) | Mar 19, 2024 | |||
| Valuation | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 518.49M | |||
| Enterprise Value | 440.73M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.05 | |||
| Earnings Per Share Growth | -101.93% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.36 | |||
| Price/Book (Q) | 1.21 | |||
| Enterprise Value/Revenue (TTM) | 0.30 | |||
| Price | $15.93 | |||
| Enterprise Value/EBITDA (TTM) | 14.19 | |||
| Enterprise Value/EBIT | 33.34 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 33.06M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 561 998 2232 | |||
| Address | 6551 Park of Commerce Boulevard, N.W. Boca Raton, FL 33487 | |||
| Website | www.crosscountry.com | |||
| Country | United States | |||
| Year Founded | 1986 | |||
| Profitability | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 0.91% | |||
| Profit Margin | -0.12% | |||
| Management Effectiveness | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.27% | |||
| Return on Equity | -- | |||
| Income Statement | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.45B | |||
| Total Revenue (TTM) | 1.45B | |||
| Revenue Per Share | $43.80 | |||
| Gross Profit (TTM) | 302.75M | |||
| EBITDA (TTM) | 31.05M | |||
| EBIT (TTM) | 13.22M | |||
| Net Income (TTM) | -1.77M | |||
| Net Income Avl. to Common (TTM) | -1.77M | |||
| Total Revenue Growth (Q YOY) | -28.75% | |||
| Earnings Growth (Q YOY) | -80.06% | |||
| EPS Diluted (TTM) | -0.05 | |||
| EPS Diluted Growth (Q YOY) | -78.50% | |||
| Balance Sheet | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 64.02M | |||
| Cash Per Share (Q) | $1.94 | |||
| Total Current Assets (Q) | 336.59M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 424.69M | |||
| Current Ratio (Q) | 2.789 | |||
| Book Value Per Share (Q) | $13.04 | |||
| Total Assets (Q) | 597.42M | |||
| Total Current Liabilities (Q) | 120.68M | |||
| Total Debt (Q) | 4.41M | |||
| Total Liabilities (Q) | 172.73M | |||
| Total Common Equity (Q) | 424.69M | |||
| Cash Flow | CCRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -9.06M | |||
| Cash from Financing (TTM) | -49.19M | |||
| Net Change in Cash (TTM) | 49.72M | |||
| Levered Free Cash Flow (TTM) | 117.86M | |||
| Cash from Operations (TTM) | 107.96M | |||
